Concepedia

Publication | Closed Access

Management of Paediatric Patients With Medically Refractory Crohn’s Disease Using Ustekinumab: A Multi-Centred Cohort Study

62

Citations

22

References

2018

Year

Abstract

Subcutaneous UST should be considered a viable therapeutic option for paediatric patients who are refractory to other biological agents. Prospective randomised trials are needed.

References

YearCitations

Page 1